Artemis Investment Management LLP purchased a new position in shares of Teladoc Health Inc (NYSE:TDOC) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 232,876 shares of the health services provider’s stock, valued at approximately $20,114,000.

Several other institutional investors and hedge funds have also modified their holdings of the company. National Asset Management Inc. acquired a new stake in shares of Teladoc Health during the third quarter worth $224,000. Swiss National Bank increased its position in shares of Teladoc Health by 1.2% in the third quarter. Swiss National Bank now owns 97,900 shares of the health services provider’s stock worth $8,454,000 after purchasing an additional 1,200 shares during the period. SG Americas Securities LLC increased its position in shares of Teladoc Health by 665.4% in the third quarter. SG Americas Securities LLC now owns 22,793 shares of the health services provider’s stock worth $1,968,000 after purchasing an additional 19,815 shares during the period. Motley Fool Wealth Management LLC increased its position in shares of Teladoc Health by 63.4% in the third quarter. Motley Fool Wealth Management LLC now owns 155,996 shares of the health services provider’s stock worth $13,470,000 after purchasing an additional 60,525 shares during the period. Finally, Motley Fool Asset Management LLC increased its position in shares of Teladoc Health by 50.0% in the third quarter. Motley Fool Asset Management LLC now owns 75,000 shares of the health services provider’s stock worth $6,476,000 after purchasing an additional 25,000 shares during the period.

A number of brokerages recently commented on TDOC. Jefferies Financial Group set a $90.00 price target on Teladoc Health and gave the stock a “buy” rating in a research report on Friday, September 28th. Robert W. Baird raised their price target on Teladoc Health from $65.00 to $80.00 and gave the stock a “neutral” rating in a research report on Friday, September 28th. Canaccord Genuity raised their price target on Teladoc Health from $86.00 to $94.00 and gave the stock a “buy” rating in a research report on Friday, September 28th. Citigroup restated a “buy” rating and issued a $95.00 price target on shares of Teladoc Health in a research report on Friday, September 28th. Finally, Cantor Fitzgerald raised their price target on Teladoc Health from $52.00 to $83.00 and gave the stock a “neutral” rating in a research report on Friday, September 28th. They noted that the move was a valuation call. Four equities research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $82.95.

Teladoc Health stock opened at $54.76 on Wednesday. Teladoc Health Inc has a 12-month low of $30.85 and a 12-month high of $89.05. The company has a current ratio of 8.99, a quick ratio of 8.99 and a debt-to-equity ratio of 0.40. The stock has a market capitalization of $4.14 billion, a price-to-earnings ratio of -33.19 and a beta of 0.96.

Teladoc Health (NYSE:TDOC) last released its earnings results on Thursday, November 1st. The health services provider reported ($0.34) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.36) by $0.02. Teladoc Health had a negative return on equity of 14.05% and a negative net margin of 31.32%. The firm had revenue of $111.00 million for the quarter, compared to analysts’ expectations of $109.94 million. During the same quarter in the previous year, the business posted ($0.55) earnings per share. The business’s revenue for the quarter was up 61.6% on a year-over-year basis. As a group, equities analysts anticipate that Teladoc Health Inc will post -1.47 earnings per share for the current fiscal year.

In other Teladoc Health news, insider Lewis Levy sold 1,284 shares of Teladoc Health stock in a transaction dated Thursday, November 15th. The stock was sold at an average price of $57.24, for a total value of $73,496.16. Following the transaction, the insider now owns 1,284 shares in the company, valued at $73,496.16. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, VP Mark Hirschhorn sold 35,000 shares of the business’s stock in a transaction dated Tuesday, September 25th. The stock was sold at an average price of $80.42, for a total value of $2,814,700.00. Following the sale, the vice president now owns 10,000 shares in the company, valued at $804,200. The disclosure for this sale can be found here. In the last quarter, insiders sold 210,929 shares of company stock worth $15,224,945. Company insiders own 3.95% of the company’s stock.

TRADEMARK VIOLATION WARNING: This report was originally posted by Daily Political and is the sole property of of Daily Political. If you are reading this report on another domain, it was illegally stolen and republished in violation of U.S. and international trademark & copyright legislation. The original version of this report can be accessed at https://www.dailypolitical.com/2018/11/21/artemis-investment-management-llp-takes-position-in-teladoc-health-inc-tdoc.html.

About Teladoc Health

Teladoc Health, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Featured Story: Fundamental Analysis – How It Helps Investors

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health Inc (NYSE:TDOC).

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.